Tobias Toennis
Overview
Explore the profile of Tobias Toennis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schnabel R, Benezet-Mazuecos J, Becher N, McIntyre W, Fierenz A, Lee S, et al.
Eur Heart J
. 2024 Sep;
45(46):4902-4916.
PMID: 39222018
Background And Aims: The optimal antithrombotic therapy in patients with device-detected atrial fibrillation (DDAF) is unknown. Concomitant vascular disease can modify the benefits and risks of anticoagulation. Methods: These pre-specified...
2.
Diener H, Becher N, Sehner S, Toennis T, Bertaglia E, Blomstrom-Lundqvist C, et al.
J Am Heart Assoc
. 2024 Aug;
13(17):e036429.
PMID: 39190564
Background: Short and rare episodes of atrial fibrillation (AF) are commonly detected using implanted devices (device-detected AF) in patients with prior stroke or transient ischemic attack (TIA). The effectiveness and...
3.
Becher N, Metzner A, Toennis T, Kirchhof P, Schnabel R
Eur Heart J
. 2024 Jul;
45(31):2824-2838.
PMID: 38953776
Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is not a dichotomous disease trait. Technological innovations enable long-term rhythm monitoring in many patients and can estimate AF burden. These...
4.
Wormann J, Strik M, Jurisic S, Stout K, ElRefai M, Becher N, et al.
Europace
. 2024 Jun;
26(7).
PMID: 38885309
Aims: Subcutaneous implantable cardioverter-defibrillators (S-ICDs) have become established in preventing sudden cardiac death, with some advantages over transvenous defibrillator systems, including a lower incidence of lead failures. Despite technological advancements,...
5.
Wormann J, Strik M, Jurisic S, Stout K, ElRefai M, Becher N, et al.
Europace
. 2024 Jun;
26(6).
PMID: 38861398
Aims: Subcutaneous implantable cardioverter-defibrillators (S-ICDs) offer potentially distinct advantages over transvenous defibrillator systems. Recent randomized trials showed significantly lower lead failure rates than transvenous ICD. Still, S-ICDs remain associated with...
6.
Linz D, Andrade J, Arbelo E, Boriani G, Breithardt G, Camm A, et al.
Europace
. 2024 Apr;
26(4).
PMID: 38591838
Aims: Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated with a...
7.
Lip G, Nikorowitsch J, Sehner S, Becher N, Bertaglia E, Blomstrom-Lundqvist C, et al.
Eur Heart J
. 2024 Apr;
45(19):1733-1737.
PMID: 38591192
No abstract available.
8.
Becher N, Toennis T, Bertaglia E, Blomstrom-Lundqvist C, Brandes A, Cabanelas N, et al.
Eur Heart J
. 2023 Nov;
45(10):837-849.
PMID: 37956458
Background And Aims: Patients with long atrial high-rate episodes (AHREs) ≥24 h and stroke risk factors are often treated with anticoagulation for stroke prevention. Anticoagulation has never been compared with...
9.
Kirchhof P, Toennis T, Goette A, Camm A, Diener H, Becher N, et al.
N Engl J Med
. 2023 Aug;
389(13):1167-1179.
PMID: 37622677
Background: Device-detected atrial high-rate episodes (AHREs) are atrial arrhythmias detected by implanted cardiac devices. AHREs resemble atrial fibrillation but are rare and brief. Whether the occurrence of AHREs in patients...
10.
Toennis T, Bertaglia E, Brandes A, Dichtl W, Fluschnik N, de Groot J, et al.
Europace
. 2023 Jun;
25(7).
PMID: 37345804
Atrial high-rate episodes (AHRE) are atrial tachyarrhythmias detected by continuous rhythm monitoring by pacemakers, defibrillators, or implantable cardiac monitors. Atrial high-rate episodes occur in 10-30% of elderly patients without atrial...